Mumbai, June 19 -- The newly formed wholly owned subsidiary namely Morepen Labs - FZCO, will trade in pharmaceuticals/ medicines (outside UAE).
The company has subscribed 5000 ordinary shares of AED 10 each, aggregating to AED 50,000. The incorporated entity being a wholly owned subsidiary, is a related party of the company.
Morepen Laboratories is a vertically integrated, innovation-led pharmaceutical and healthcare company delivering highquality APIs, branded generics, medical devices, and consumer wellness products to over 80 countries worldwide.
The company's consolidated net profit declined 28.18% to Rs 20.31 crore despite a 10.11% jump in revenue from operations to Rs 465.85 crore in Q4 FY25 over Q4 FY24.
The counter declined 2....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.